These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36543337)

  • 1. Covid-19: What can China learn from Hong Kong and Singapore about exiting zero covid?
    Owens D; Parry J
    BMJ; 2022 Dec; 379():o3043. PubMed ID: 36543337
    [No Abstract]   [Full Text] [Related]  

  • 2. Age, source, and future risk of COVID-19 infections in two settings of Hong Kong and Singapore.
    Zhu S; Tao J; Gao H; He D
    BMC Res Notes; 2020 Jul; 13(1):336. PubMed ID: 32660556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to organise travel restrictions in the new future: lessons from the COVID-19 response in Hong Kong and Singapore.
    Lai D; Cai Y; Chan TH; Gan D; Hurson AN; Zhang YD
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35228258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shift of percent excess mortality from zero-COVID policy to living-with-COVID policy in Singapore, South Korea, Australia, New Zealand and Hong Kong SAR.
    Cao X; Li Y; Zi Y; Zhu Y
    Front Public Health; 2023; 11():1085451. PubMed ID: 37020822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study.
    Gwee SXW; Chua PEY; Wang MX; Pang J
    BMC Infect Dis; 2021 Aug; 21(1):799. PubMed ID: 34380452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
    Voo TC; Ballantyne A; Ng CJ; Cowling BJ; Xiao J; Phang KC; Kaur S; Jenarun G; Kumar V; Lim JM; Tun ZM; Wong NCB; Tam CC
    Int J Infect Dis; 2022 Jul; 120():51-58. PubMed ID: 35430376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitigation policies, community mobility, and COVID-19 case counts in Australia, Japan, Hong Kong, and Singapore.
    Hakim AJ; Victory KR; Chevinsky JR; Hast MA; Weikum D; Kazazian L; Mirza S; Bhatkoti R; Schmitz MM; Lynch M; Marston BJ
    Public Health; 2021 May; 194():238-244. PubMed ID: 33965795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan, and Singapore.
    Kwok KO; Chan HHH; Huang Y; Hui DSC; Tambyah PA; Wei WI; Chau PYK; Wong SYS; Tang JWT
    J Hosp Infect; 2020 Aug; 105(4):682-685. PubMed ID: 32446721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tale of 3 Asian Cities: How is Primary Care Responding to COVID-19 in Hong Kong, Singapore, and Beijing.
    Wong SYS; Tan DHY; Zhang Y; Ramiah A; Zeng X; Hui E; Young DYL
    Ann Fam Med; 2021; 19(1):48-54. PubMed ID: 33431392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collateral Impact of COVID-19 Prevention Measures on Re-Emergence of Scarlet Fever and Pertussis in Mainland China and Hong Kong China.
    He Y; Ma C; Guo X; Pan J; Xu W; Liu S
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    De Foo C; Grépin KA; Cook AR; Hsu LY; Bartos M; Singh S; Asgari N; Teo YY; Heymann DL; Legido-Quigley H
    Lancet; 2021 Oct; 398(10311):1547-1551. PubMed ID: 34619099
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychological and behavioral responses to the declaration of COVID-19 as a pandemic: A comparative study of Hong Kong, Singapore, and the U.S.
    Liu JJ; Mukhopadhyay A; Yeung CW
    PLoS One; 2022; 17(10):e0275854. PubMed ID: 36215259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of coronary heart disease in populations of Chinese descent.
    Dwyer T; Emmanuel SC; Janus ED; Wu Z; Hynes KL; Zhang C
    Atherosclerosis; 2003 Apr; 167(2):303-10. PubMed ID: 12818413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The guiding principles for populational COVID-19 vaccine selection: A normative analysis through comparison of the strategies in Hong Kong and Singapore.
    Chan TK
    J Glob Health; 2022; 12():03004. PubMed ID: 35265324
    [No Abstract]   [Full Text] [Related]  

  • 15. A metropolitan-scale, three-dimensional agent-based model to assess the effectiveness of the COVID-19 Omicron wave interventions in a hyperdense city: a case study of Hong Kong.
    Koh K; Tang KC; Axhausen K; Loo BPY
    Int J Infect Dis; 2022 Sep; 122():534-536. PubMed ID: 35793754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic determinants of perinatal statistics of Chinese: demography of China, Hong Kong and Singapore.
    Fung KP; Wong TW; Lau SP
    Int J Epidemiol; 1989 Mar; 18(1):127-31. PubMed ID: 2722355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with COVID-19 vaccination intent in Singapore, Australia and Hong Kong.
    Shah S; Gui H; Chua PEY; Tan JB; Suen LK; Chan SW; Pang J
    Vaccine; 2022 May; 40(21):2949-2959. PubMed ID: 35414417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997.
    Luo J; Chia KS; Chia SE; Reilly M; Tan CS; Ye W
    Eur J Epidemiol; 2007; 22(8):513-21. PubMed ID: 17594525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 primary care response and challenges in Singapore: a tale of two curves.
    Liow Y; Loh VWK; Goh LH; Tan DHY; Tan TL; Leong CK; Young DYL
    Hong Kong Med J; 2021 Feb; 27(1):70-72. PubMed ID: 33558446
    [No Abstract]   [Full Text] [Related]  

  • 20. Suicides in Hong-Kong and Singapore: a tale of two cities.
    Yip PS; Tan RC
    Int J Soc Psychiatry; 1998; 44(4):267-79. PubMed ID: 10459510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.